AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Nuvation Bio Inc. (NUVB) has been beaten down lately with too much selling pressure. While the stock has lost 24.1% over the ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

The medical biotechnology company built a 100,000-square-foot lab near the airport to receive, treat and send blood cancer ...

Instil Bio said its subsidiary has discontinued clinical development of AXN-2510 and terminated its collaboration agreement with ImmuneOnco Biopharmaceuticals (Shanghai) for AXN-2510 and AXN-27M.

If you’re a candidate for C-suite, Partner, or Board roles, you’ll be asked for a bio as part of the process. For some roles reporting to the C-suite, you may need a bio as well. Employers evaluating ...

Jan 6 () - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that ​uses artificial intelligence ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...